SOLUtion Medical

Simplifying Adrenal Crisis Health Management

We are passionate about what we do

SOLUtion is an early-stage medical device company based in Philadelphia, PA focused on simplifying adrenal crisis health management. We specifically aim to improve the administration efficacy of life saving injectable medication with our TwistJect™ autoinjector for the 144 million people worldwide living with idiopathic adrenal insufficiency including Addison’s Disease and Congenital Adrenal Hyperplasia.

Help us accelerate change

Adrenal crisis: Still a deadly event in the twenty first century

Adrenal crisis is a life-threatening medical emergency, associated with a high mortality unless it is appropriately recognized and early treatment is rendered. Nearly 144 million people worldwide are adrenal insufficient (AI). Despite it being a treatable condition for almost 70 years, failure of adequate preventive measures or delayed treatment has often led to unnecessary deaths. 1,2

144M

Adrenal insufficient patients worldwide

85% of patients

Report non-adherence with life-saving medication

AI patients are 4X

More likely to be hospitalized

$28k

Per Adrenal insufficiency hospitalization

Testimonials

Designed by users for users, TwistJect ™ provides people reliable, accurate, and intuitive life-saving care.

Reliable
Accurate
Intuitive

The current standard of care in times of adrenal crisis includes the Act-o-vial®, medical packaging requiring an average of twelve user steps for injection. The Act-o-vial® was designed to be utilized by trained medical personnel and not a layperson or an individual living with adrenal insufficiency. 

 

Accelerators

SOLUtion Medical has been recognized for its innovative approach to adrenal crisis health management with its patent-pending TwistJect™  device. Since inception in 2019, SOLUtion Medical has gained recognition throughout Philadelphia and within the adrenal insufficient community.

 

Collaborators

Who we are

Julia Anthony, MSID

Chief Executive Officer & Founder

Salt-Wasting Congenital Adrenal Hyperplasia (SWCAH) Survivor 

julia@solutionmedllc.com

Jonathan Kiel, Ph.D.

Chief Scientific Officer & Co-Founder

       Chemical Engineering and Materials Science            Co-founder of Nima

jonathan@solutionmedllc.com

Marika Agnello, PhD Candidate

Chief Research Officer

Addison’s Disease Survivor  

marika@solutionmedllc.com

Gabrielle Morgalo

Events Associate

       Chemical Engineerin         

gabrielle@solutionmedllc.com

Philadelphia, PA
(484) 416 -1261
Info@solutionmedllc.com

1) Huecker MR, Dominique E. Adrenal Insufficiency. [Updated 2019 May 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan.

2) Am J Med. 2016 Mar;129(3):339.e1-9. doi: 10.1016/j.amjmed.2015.08.021. Epub 2015 Sep 9.

Navigation

  • About SOLUtion
  • Patient advocacy
  • Investors and media
  • Gala
  • Career

Newsletter

© 2020 All rights reserved